Ultragenyx Pharma (RARE) PT Raised to $110 at Canaccord Genuity
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Price: $26.49 +0.42%
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Canaccord Genuity analyst Whitney Ijem raised the price target on Ultragenyx Pharma (NASDAQ: RARE) to $110.00 (from $107.00) while maintaining a Buy rating.
You May Also Be Interested In
- Tactical Resources completes Plum merger, set for Nasdaq debut
- Tactical Resources Completes Business Combination with Plum Acquisition Corp. III and Prepares for Nasdaq Listing
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
